The 67-kD cytosolic protein (p67-phox) is an essential component of the superoxide-generating system in phagocytes, and its defect is known to cause chronic granulomatous disease (CGD). We sequenced p67-phox cDNA from one of seven patients found in Japan and his parents. In the patient's cDNA, homozygous AG dinucleotide insertion at position 399 (or 401) was found together with three other homozygous substitutions in a coding region (A-542 to G, T-895 to C and A-983 to G) compared with the sequence reported for HL-60 cells. In cDNA from his parents, the AG insertion was found to be heterozygous. In contrast, the other three substitutions were found homozygously in his father's specimen and the latter two in his mother's specimen. The substitution of A-542 to G was heterozygous in his mother's cDNA.
The 67-kD cytosolic protein (p67-phox) is an essential component of the superoxide-generating system in phagocytes, and its defect is known to cause chronic granulomatous disease (CGD). We sequenced p67-phox cDNA from one of seven patients found in Japan and his parents. In the patient's cDNA, homozygous AG dinucleotide insertion at position 399 (or 401) was found together with three other homozygous substitutions in a coding region (A-542 to G, T-895 to C and A-983 to G) compared with the sequence reported for HL-60 cells. In cDNA from his parents, the AG insertion was found to be heterozygous. In contrast, the other three substitutions were found homozygously in his father's specimen and the latter two in his mother's specimen. The substitution of A-542 to G was heterozygous in his mother's cDNA.
HAGOCYTES HAVE a special electron transport system on their plasma membrane that carries an electron from NADPH to molecular oxygen to generate superoxide anion on stimulation. The anion is released to the outside of the cells or inside of phagosomes,' where other active oxygen species are formed secondarily and may be used for killing infectious agents. Chronic granulomatous disease (CCD) is a rare inherited disorder where phagocytes cannot generate superoxide anion and is characterized by recurrent, life-threatening infections with catalase-positive microorganisms. 2 The superoxide generating system in phagocytes consists of a membrane-bound catalytic component, cytochrome b558, and cytosolic components that seem to be required for activation of the system. A functionally active enzyme complex is formed on stimulation by assembly of the necessary components on the plasma membrane. The cytochrome is composed of the large and small subunits, designated as gp91-phox and p22-phox, respectively. CCD occurs as an X-linked and autosomal disorder, and the gene responsible for the former CCD codes for the large subunit3 and the latter codes for the small subunit4 and the cytosolic components. As cytosolic components, Nunoi et al' and Volpp et a16 found 47-kD and 67-kD (or 65-kD) proteins, designated now as fl7-phox and p67-phox, respectively. Either of these proteins, if it is not p22-phox deficiency, is defective in autosomal type of CCD. A small GTP binding protein, ruc p21 in cytosol, is also involved in the reaction, though no corresponding CCD patient is known.
Of four types of CCD mentioned above, p67-phox deficiency is known to be rare in the United state^,^ [8] , Europe,'
and Japan (manuscript in preparation). Although cDNA that codes p67-phox was cloned from HL60 cells and sequenced in 1990: and the genomic organization was reported in 1994," no mutation in patients with p67-phox-deficient CCD has so far been reported. Very recently, de Boer et all' reported that a mutation, resulting in a nonconservative amino acid change in p67-phox (Gly-78 to Glu), may be responsible for the protein deficiency in one CCD patient. We performed molecular analysis of CCD patients with p67- The AG insertion would induce a frame shift and bring about a stop codon at the position of 433. However, the other three differences would give insignificant changes for the protein function, if any, because the substitutions of A-542 to G and A-983 to G resutt in the conservative amino acid transitions, ie, Lys-180 to Arg and Lys-327 to Arg. and that of T-895 to C no amino acid change. Neutrophils from the patients completely lacked superoxide generating activity whereas those from his parents generated substantial amounts of superoxide anion upon stimulation. Thus, it is concluded that the AG dinucleotide insertion is responsible for the disease in this patient. 0 1995 by The American Society of Hematology.
phox deficiency and found a homozygous AG dinucleotide insertion in one patient, which would bring about a frame shift into the fragment resulting in an early stop codon.
MATERIALS AND METHODS
Clinical history of the patient. The patient KA is a 19-year-old man. His first episode of infection was at age 3 when he had perianal abscess, liver abscess, severe lung abscess, pneumonia with Aspergillus infection, and severe spinal Aspergillus osteomyelitis. Since then, he suffered from recurrent infections at age 4, 6, 1 I , 15, and 19 years. His clinical course was worse as compared with the other four patients with p67-phox deficiency found in Japan. CGD was diagnosed by no reduction of nitroblue tetrazolium and cytochrome c in neutrophils.
Epstein-Barr virus (EBV)-transformed cell lines. The patient's lymphoid cell lines were established as previously described.'2 In brief, the mononuclear cells were obtained from patient's peripheral blood and exposed for 2 hours to EBV from B95-8 cultured medium.
The cells were cultured for about 4 weeks for establishment.
Cell-free assay. To know whether or not functional p67-phox is present in cytosol in EBV-transformed B-cell lines, cell-free assays were performed using neutrophil membrane? A mixture of plasma membrane prepared from normal neutrophils and cytosol from EBVtransformed B-cell lines were incubated at 25°C in 100 m m o K of sodium dodecyl sulfate (SDS). NADPH was added to start the reaction after 3 minutes. Production of superoxide anion was assayed Imrnunoblor analysis. The presence of the large and small subunits of cytochrome b558 and p47-phox was determined on Western blots after polyacrylamide gel electrophoresis (PAGE). Antibodies used for the blots were polyclonal antibodies specific for gp9 I -phox, p22-phox, p47-phox, and p67-phox, ' I and monoclonal antibodies against recombinant p47-and p67-phox. I' RNA preparation and cDNA synthesis. Total cellular RNA was isolated from the transformed B cells or peripheral leukocytes from the patient and his parents according to the method previously described.'* The first-strand cDNA was generated from about 20 ng of total cellular RNA using reverse transcriptase from Molony murine leukemia virus in a reaction mixture of 50 mmol/L TRIS-HCI (pH 8.3), 75 m m o n KCI, 10 mmol/L ditbiothreitol (DTT), 3 mmoliL MgClz, 0.5 mmol/L dNTPs (dATP, dCTP, dGTP and dTTP), and 30 pm01 of specific antisense primer as shown in Table l . Thirty cycles of amplification by polymerase chain reaction (PCR) was performed in 5 mmoliL Taps-HC1 (pH 8.3) , 5 mmol/L MgCI?, 50 mmol/L KCI, 0.2 mmoVL DTT, 0.2 mmoVL dNTPs, and 4 U of Tay DNA polymerase using Quick Thermo I1 (Nippon Genetics CO, Ltd, Tokyo, Japan). The following conditions were used for PCR: denaturation at 94°C for 1 minute, hybridization at 55°C for I minute, and extention at 72°C for 1 minute. Sets of primers 1/2, 3/4, 5/6, and 7/8 ( Table 1) were used for amplification of each fragment of p67-phox cDNA. The PCR products were precipitated with ethanol and separated on a 1.0% agarose gel. DNA was extracted from the gel. 
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DNA sqrwrrcing. Cycle sequence method was employed using Taq Dye Deoxy Terminator Sequencing Kit (Perkin Elmer Japan, Chiba) with 70 to 80 ng of PCR product as a template using the sequence primers and that of PCR amplifications (Table l) . Sequencing was performed with an autosequencer (AB1 model 373A: Perkin Elmer Japan). We sequenced both strands. Some of PCR fragments were cloned into pUC18 and they were sequenced. where 1 mg of plasmid DNA was used as a template.
Mtrrcvitrls. Materials used included Taps ([2-Hydroxy-l,l-bis-(hydroxymethyl)ethyl] amino)-l-propane sulfonic acid), AB1 Taq Dye Deoxy Terminator Sequencing Kit (Perkin Elmer Japan), and Taq DNA polymerase (Boehringer Mannheim, Tokyo, Japan).
RESULTS
A patient (KA), whose clinical features are shown in Materials and Methods, was diagnosed as having CGD by complete lack of nitro blue tetrazolium reducing-and cytochrome c reducing-activities of his neutrophils on stimulation. Cytosol of the EBV-transformed B-cell lines established from the patient did not support superoxide-generating activity of neutrophil membrane in vitro in contrast to that of the B-cell lines from normal volunteers, which supported the activity. However, addition of recombinant p67-phx restored the activity (data not shown). In membrane fraction from the patient's neutrophils, normal levels of the large and small subunits of cytochrome bSSX were found by Western blots using the peptide-directed polyclonal antibodies. The cytosol of 
the patient's neutrophils contained a significant amount of p47-phox. whereas p67-phox protein was not detected (see Fig 2) , even when 10 times as much cytosol protein was used for Western blot analysis using the monoclonal and the polyclonal antibodies. EBV-transformed B-cell lines established form the patient's and normal peripheral leukocytes were used to isolate mRNA. The mRNA obtained was converted to cDNA with the aid of a reverse transcriptase using specific primer for the gene. Full-length p67-phox coding sequence was amplified into four overlapping fragments by the PCR method (Table l) . Northern blot analysis of the patient's EBV-transformed B-cell line exhibited the presence of normal size and amount of mRNA of the gene, and the PCR fragments obtained were similar in sizes and amounts to the fragments obtained from control B-cell lines. When these fragments were sequenced, homozygous AG dinucleotide insertion at position 399 (or 401) was found (Fig 1 a-1,a-2) . As a result, a frame shift would be introduced into the fragment, resulting in an early stop codon at the position 433. Beside this insertion, three other homozygous differences, compared with the reported sequence," were found in the patient's specimen. They are substitutions of A to G at position 542, T to C at 895, and A to G at 983 (Fig lb-d and Table 2 ). The substitutions of positions 542 and 983 would cause the amino acid substitution of lysine to arginine, and that of 895 no substitution. We had sequenced in both strands and the sequence abnormalities were found in both strands from the patient.
To confirm that the AG dinucleotide insertion but not the other differences are responsible for the disease, the RT-PCR products from the peripheral blood of the patient's parents were cloned into pBluescript vector and 5 clones for each fragment were sequenced. In his father's specimen, 3 clones of 5 had the AG insertion at position 399 (or 401), whereas all other substitutions were found homozygously (Table 2) . In his mother's specimen, the AG insertion and A-542 to G substitution were found to be heterozygous, and two other substitutions, namely T-895 to C and A-983 to G, were homozygous. We further investigated 10 control alleles and 6 alleles from other types of CGD patients with this method. In all alleles examined, nucleotide in positions 542 and 983 was G, whereas that in position 895 was T (Table 2, Control).
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DISCUSSION
We found homozygous AG dinucleotide insertion at position 399 (or 401) in one CGD patient with p67-phox deficiency. It is known that insertion of one or two novel bases into a coding region causes an alteration of the reading frame of the encoded protein that usually leads to termination of translation at some distance downstream. In the present case, the dinucleotide insertion would introduce a fame shift to the gene and hence result in an early stop codon at the position 433. No protein fragment of p67-phon was found in neutrophils or EBV-transformed B lymphocytes from the patient. EBV-transformed cells from normal B lymphocytes contain p67-phox. Therefore, the dinucleotide insertion seems to be responsible for the disease.
It was reported that a substantial proportion of mutations causing human genetic disease was the insertion, although the vast majority are point mutations and deletions." Dinucleotide insertion was reported in a pyruvate dehydrogenase Ela deficiency,16 in a spherocyt~sis,'~ and in a cystic fibrosis." In all cases, the insertions seem to be associated with a run of repeated element; ie, CCTT TT TTGA in pyruvate dehydrogenase Ela deficiency, ACTG E TGAC in a spherocytosis, and GGqT MATTCAA in a cystic fibrosis, where insertions are shown in bold characters. In the present case, the DNA sequence surrounding the insertion is AG AAGGAGGAA, which is also associated with a run of repeated element consisting of A and G. Such a DNA sequence may responsible for the AG insertion.
Other differences of sequence found in the patient's specimen compared with the one reported were substitutions of A-983, T-895, and A-542 to G, C, and G, respectively. The reported sequence was of cDNA derived from HL-60 cells.' These substitutions found here would accompany no amino acid transition or the conservative amino acid transition from lysine to arginine. Therefore, these differences are supposed to influence little structural change in this protein and its functions. de Boer et all' recently showed exactly the same difference of A-983 to G in one patient with p67-phox deficiency and established its frequency by examining 38 normal donors. They found that 36 were homozygous for G-983 and 2 were heterozygous for both G and A. None were homozygous for A-983. In our own investigation, all 16 alleles examined were homozygous for G-983. Therefore, the A-983 seems to be very rare even if it is a polymorphism, and the vast majority of this position may be G.
We showed that all 16 alleles examined were homozygous for T-895, like cDNA from HL-60. This is in contrast to those from the patient and his parents, where all alleles were homozygous for C-895. In a CGD patient with p67-phox deficiency, and in multiple clones from a cDNA library and a genomic library from a different person, nucleotide in position 895 was reported to be C." Therefore, it seems likely that the nucleotides found in this position are a polymorphism. Concerning position 542, we found A only in one allele from the patient's mother. All other alleles examined were G.
CGD associated with p67-phox is rare in the United States and Europe compared to that with p47-phox, and only five patients with p67-phox deficiency have been reported in the literature.'* In Japan, such CGD patients are also rare, being found in 7 of 90 CGD patients (manuscript in preparation). In all CGD cases with p47-phox deficiency in the United States, Europe, and Japan, the defect was identified to be dinucleotide GT (or TG) deletion at the base around 75 in the coding sequence for the protein. In contrast, AG dinucleotide insertion was only found in l of 5 CGD patients with p67-phox deficiency, and other 4 did not have the insertion. Boer et all' reported that a missense mutation of G-233 caused the instability of p67-phox protein in one CGD patient.
